Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Théo de Witte, Georg‐Nikolaus Franke et al.|Journal of Clinical Oncology|2017Cited by 248
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-TransportersElisabeth Groß, Thomas Weber|Cancers|2023Cited by 8